Ibrahim et al. found CD38 expression in approximately 27–46% of chronic lymphocytic leukemia (CLL) cases, with higher expression levels associated with increased aggressiveness and a poorer prognosis [85]. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.